首頁 > 市場調查報告書 > 製藥

消化器

市場調查報告書

商品編碼

1692401

抗酸藥市場 - 全球行業規模、佔有率、趨勢、機會和預測，按類型（片劑、液體、其他）、按最終用途（零售藥房、醫院藥房、網上藥房）、按地區和競爭進行細分，2020-2030 年預測

Antacids Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Tablet, Liquid, others), By End-use (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), By Region and Competition, 2020-2030F

出版日期: 2025年03月24日 | 出版商:

TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球制酸劑市場價值為 68.7 億美元，預計到 2030 年將達到 84.1 億美元，預測期內複合年成長率為 3.43%。抗酸藥是一類非處方藥（OTC）或處方藥，主要用於緩解與胃酸過多和胃腸道酸性相關的症狀。它們透過中和或減少胃內容物的酸度來發揮作用，有助於緩解胃灼熱、消化不良和胃部不適等症狀。抗酸藥含有鹼性活性成分。食用後，這些成分會與胃中多餘的鹽酸發生反應並中和該物質，從而提高 pH 值並降低酸度。抗酸藥物可作為化學緩衝劑，將胃的 pH 值維持在正常或較低的酸性範圍內。這種緩衝作用有助於減輕酸性胃內容物逆流至食道所引起的不適，而逆流至食道是導致胃灼熱的常見原因。抗酸藥物通常用於緩解胃灼熱、胃酸倒流、消化不良和胃部不適的症狀。它們可以快速緩解症狀，適合短期治療輕度至中度酸性相關疾病。不健康的飲食習慣，包括食用辛辣和酸性食物以及不規則的飲食時間，都會導致酸相關疾病。這些飲食習慣的改變導致了對抗酸藥物的需求。全球老化人口更容易患上酸性相關疾病，而且這種疾病通常隨著年齡的成長而變得更加常見。隨著老年人口的成長，對抗酸藥的需求也隨之增加。抗酸藥是無需處方的非處方藥（OTC），這使得消費者可以輕鬆獲得它們。這種便利鼓勵了自我藥療並推動了銷售。製藥公司不斷創新開發新的制酸劑型，為消費者提供更廣泛的、更有效、更快的產品。

市場概況
預測期	2026-2030
2024 年市場規模	68.7 億美元
2030 年市場規模	84.1 億美元
2025-2030 年複合年成長率	3.43%
成長最快的領域	藥片
最大的市場	北美洲

主要市場促進因素

改變飲食習慣

主要市場挑戰

通用競爭

主要市場趨勢

電子商務與網路零售

Global Antacids Market was valued at USD 6.87 billion in 2024 and is expected to reach USD 8.41 billion by 2030 with a CAGR of 3.43% during the forecast period. Antacids are a category of over the counter (OTC) or prescription medications that are primarily used to relieve symptoms associated with excessive stomach acid and acidity in the gastrointestinal tract. They work by neutralizing or reducing the acidity of the stomach's gastric contents, which can help alleviate symptoms such as heartburn, acid indigestion, and upset stomach. Antacids contain active ingredients that are alkaline (basic) in nature. When consumed, these ingredients react with and neutralize the excess hydrochloric acid in the stomach, raising the pH level and reducing the acidity. Antacids act as chemical buffers, maintaining the pH of the stomach within a normal or less acidic range. This buffering effect helps alleviate the discomfort caused by the regurgitation of acidic stomach contents into the esophagus, which is a common cause of heartburn. Antacids are typically used to relieve symptoms of heartburn, acid reflux, acid indigestion, and upset stomach. They can provide rapid relief, making them suitable for short-term management of mild to moderate acid-related conditions. Unhealthy dietary habits, including the consumption of spicy and acidic foods, and irregular eating schedules, contribute to acid-related disorders. These dietary changes drive the need for antacids. The global aging population is more prone to acid-related disorders, which often become more common with age. As the elderly demographic grows, so does the demand for antacids. The availability of antacids as over the counter (OTC) medications without a prescription makes them easily accessible to consumers. This convenience encourages self-medication and drives sales. Pharmaceutical companies continuously innovate and develop new antacid formulations, offering consumers a broader range of products that are more effective and faster-acting.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 6.87 Billion
Market Size 2030	USD 8.41 Billion
CAGR 2025-2030	3.43%
Fastest Growing Segment	Tablet
Largest Market	North America

Key Market Drivers

Changing Dietary Habits

Spicy and acidic foods, such as citrus fruits, tomatoes, and foods high in spices or vinegar, can trigger or exacerbate heartburn and acid reflux. As people incorporate these foods into their diets, they may experience acid-related discomfort and seek relief through antacids. Diets high in fat can slow down digestion and increase the risk of acid reflux. Fast food and processed foods, which are often high in fat, contribute to dietary habits that can lead to heartburn and indigestion. Overeating, especially in a single large meal, can put pressure on the lower esophageal sphincter (LES), allowing stomach acid to flow back into the esophagus. People with a tendency to consume big meals may experience heartburn, making antacids a go-to solution. Late-night eating can disrupt sleep patterns and increase the risk of acid reflux. As individuals develop habits of eating close to bedtime, they may experience acid-related discomfort, prompting the use of antacids.

Skipping meals or eating irregularly can lead to fluctuations in stomach acid production, increasing the likelihood of heartburn and indigestion when food is finally consumed. For some individuals, specific foods act as triggers for heartburn or indigestion. These trigger foods can vary from person to person but often include coffee, chocolate, alcohol, and mint. As people consume these foods, they may experience symptoms that lead to antacid use. Obesity is a significant risk factor for acid reflux and GERD. Dietary habits that contribute to weight gain can indirectly drive the demand for antacids as obese individuals are more prone to acid-related disorders. Diets high in processed and sugary foods can contribute to gastrointestinal issues and heartburn. As these diets become more common, the demand for antacids may increase. The consumption of caffeinated beverages like coffee and carbonated drinks can relax the LES and increase stomach acid production, potentially leading to heartburn. The globalization of food and the popularity of international cuisines can introduce people to new and spicy foods, which may be less familiar to their digestive systems and increase the likelihood of heartburn. This factor will help in the development of the Global Antacids Market.

Key Market Challenges

Generic Competition

As patents for branded antacid medications expire, generic drug manufacturers are legally allowed to produce and market their versions of the same medications. This leads to an increase in the availability of generic antacids. Generic antacids are typically more cost-effective than their branded counterparts. This price advantage is attractive to cost-conscious consumers, healthcare providers, and healthcare systems. The proliferation of generic antacid products can fragment the market, making it more challenging for branded antacids to maintain market share and premium pricing. Many consumers trust generic medications, believing that they are equivalent in quality and efficacy to their branded counterparts. This trust further drives the demand for generic antacids.

Generic antacids must meet the same regulatory standards for safety and efficacy as branded products. Once approved by regulatory agencies, they become competitive alternatives in the market. Health insurance plans and formulary lists often favor the use of generic medications, making them more accessible and cost-effective for patients. Pharmacies may dispense generic versions of antacids in place of branded products, unless specifically requested by the patient or healthcare provider. In response to generic competition, some pharmaceutical companies may choose to reduce the prices of their branded antacids or offer rebates and incentives to maintain their market share. Branded antacids invest heavily in marketing and branding to maintain consumer loyalty and differentiate their products. However, generic competition can still erode their market presence.

Key Market Trends

E-commerce and Online Retail

E-commerce and online retail provide a convenient way for consumers to purchase antacids. They can browse, compare products, and make purchases from the comfort of their homes, saving time and effort. Online platforms offer a broader selection of antacids, including different brands, formulations, and flavors. This variety allows consumers to choose products that best suit their preferences and needs. Online platforms provide detailed product information, customer reviews, and expert recommendations, enabling consumers to make informed choices when selecting antacids. Consumers can easily compare prices of antacids across multiple online retailers, helping them find the best deals and discounts.

Online retailers often carry niche or specialty antacid products, such as those with natural ingredients or unique formulations, catering to specific consumer preferences. Online shopping allows consumers to purchase antacids in bulk, potentially saving them money and ensuring a steady supply. Antacids can be delivered to the consumer's doorstep, eliminating the need for a trip to a physical store. This is particularly appealing for individuals with mobility issues or those living in remote areas. Some e-commerce platforms offer subscription services for antacids, ensuring regular and convenient delivery of these products to customers. Online shopping provides privacy and discretion, which can be important for individuals seeking relief from sensitive gastrointestinal issues.

Key Market Players

GlaxoSmithKline plc
Bayer AG
Boehringer Ingelheim International GmbH
Dr. Reddy's Laboratories Ltd.
Sanofi SA
Reckitt Benckiser Group plc
Sun Pharmaceuticals Ltd.
Takeda Pharmaceutical Company Limited
Pfizer Inc.
Procter & Gamble Co.

Report Scope:

In this report, the Global Antacids Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Antacids Market, By Type:

Tablet
Liquid
Others

Antacids Market, By End-Use:

Retail Pharmacy
Hospital Pharmacy
Online Pharmacy

Antacids Market, By region:

North America
- United States
- Canada
- Mexico
Asia-Pacific
- China
- India
- South Korea
- Australia
- Japan
Europe
- Germany
- France
- United Kingdom
- Spain
- Italy
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Antacids Market.

Available Customizations:

Global Antacids Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Applications
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Antacids Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type (Tablet, Liquid, others)
- 5.2.2. By End-use (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
5.3. Market Map

6. Asia Pacific Antacids Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By End-use
- 6.2.3. By Country
6.3. Asia Pacific: Country Analysis
- 6.3.1. China Antacids Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By End-use
- 6.3.2. India Antacids Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By End-use
- 6.3.3. Australia Antacids Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By End-use
- 6.3.4. Japan Antacids Market Outlook
  - 6.3.4.1. Market Size & Forecast
    - 6.3.4.1.1. By Value
  - 6.3.4.2. Market Share & Forecast
    - 6.3.4.2.1. By Type
    - 6.3.4.2.2. By End-use
- 6.3.5. South Korea Antacids Market Outlook
  - 6.3.5.1. Market Size & Forecast
    - 6.3.5.1.1. By Value
  - 6.3.5.2. Market Share & Forecast
    - 6.3.5.2.1. By Type
    - 6.3.5.2.2. By End-use

7. Europe Antacids Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By End-use
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Antacids Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By End-use
- 7.3.2. Germany Antacids Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By End-use
- 7.3.3. Spain Antacids Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By End-use
- 7.3.4. Italy Antacids Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type
    - 7.3.4.2.2. By End-use
- 7.3.5. United Kingdom Antacids Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type
    - 7.3.5.2.2. By End-use

8. North America Antacids Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By End-use
- 8.2.3. By Country
8.3. North America: Country Analysis
- 8.3.1. United States Antacids Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By End-use
- 8.3.2. Mexico Antacids Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By End-use
- 8.3.3. Canada Antacids Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By End-use

9. South America Antacids Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By End-use
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Antacids Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By End-use
- 9.3.2. Argentina Antacids Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By End-use
- 9.3.3. Colombia Antacids Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By End-use

10. Middle East and Africa Antacids Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By End-use
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Antacids Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By End-use
- 10.3.2. Saudi Arabia Antacids Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By End-use
- 10.3.3. UAE Antacids Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By End-use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. Global Antacids Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

16.1. Bayer AG
- 16.1.1. Business Overview
- 16.1.2. Company Snapshot
- 16.1.3. Products & Services
- 16.1.4. Financials (As Reported)
- 16.1.5. Recent Developments
- 16.1.6. Key Personnel Details
- 16.1.7. SWOT Analysis
16.2. GlaxoSmithKline plc
16.3. Boehringer Ingelheim International GmbH
16.4. Dr Reddy's Laboratories Ltd.
16.5. Sanofi SA
16.6. Reckitt Benckiser Group plc.
16.7. Sun Pharmaceuticals Ltd
16.8. Takeda Pharmaceutical Company Limited
16.9. Pfizer Inc.
16.10. Procter & Gamble Co.